Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN107759623A reveals high-yield Ruxolitinib intermediate route. Eliminates column chromatography for cost reduction and supply chain reliability in API manufacturing.
Patent CN102241679B details selective decarboxylation for Midazolam. Enhances purity and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN107759601A details high-purity Ruxolitinib synthesis. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN110845534A details a novel oxidative coupling method for phosphoramide compounds, offering high stereoselectivity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN104496979A reveals high-yield Suzuki coupling for oxazolidinone compounds. Enables cost reduction in API manufacturing with scalable high-purity processes.
Patent CN105753801B reveals Ru-catalyzed s-triazine synthesis. Offers mild conditions and scalable routes for pharmaceutical intermediate manufacturing supply chains.
Patent CN119843292B reveals electrooxidation synthesis for fluoroalkyl heterocycles. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1694878A details advanced asymmetric transfer hydrogenation for high-purity pharmaceutical intermediates, offering scalable routes for cost-effective manufacturing.
Patent CN103073475A reveals a mild lithiation route for 1-Boc-4,5-pyrroline-2-carboxylates, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel crystalline forms and purification methods for dabigatran intermediates ensuring high purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN107686456A reveals safer synthesis for quinolone intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Patent CN105061460B details novel EGFR inhibitor synthesis offering cost reduction in API manufacturing and high-purity pharmaceutical intermediates for global supply chains.
Discover the novel 7-step synthesis of Pitavastatin Calcium avoiding DIBAL-H. A scalable, high-purity route for reliable pharmaceutical intermediates supply.
Patent CN104387359A details a scalable Galangin synthesis route. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104496913B reveals high-purity pyrimidine synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Novel two-step oxidation method ensures high purity 3-cyanobenzoic acid. Reduces environmental waste and offers scalable pharmaceutical intermediates manufacturing solutions.
Novel patent CN107778279A offers safer Atorvastatin intermediate synthesis. Avoids toxic cyanide, ensures high purity, scalable for global supply chains.
Novel copper catalysis method for benzofuran-pyrrole compounds offers high yield and mild conditions, ensuring reliable supply chain and cost efficiency.
Novel 3-step semi-synthesis of 5,6-Deoxywithaferin A from Withaferin A. High yield route offers supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN110183347B discloses novel benzyl compounds for liquid phase peptide synthesis, offering superior solubility, simplified purification, and high purity for commercial manufacturing.